tirzepatide injection frederick FullScopeMD Tirzepatide Weight Loss Injections •

By 7.5mg, most researchers report consistent weekly weight loss, and by 10mg, the dual receptor activation is driving meaningful metabolic changes

While tirzepatide (marketed as Mounjaro or Zepbound ) has shown remarkable results as a dual GIP/GLP-1 receptor agonist, retatrutide takes it a step further by also targeting the glucagon receptor

Acid reflux, burping, and bloating from Mounjaro Acid reflux, burping, and bloating are common Mounjaro side effects

Peizer may recommend lab work to better evaluate hormones, metabolic markers, inflammation, recovery markers, or other important health indicators

This is a fixed physical measurement, like filling a cup halfway

Sources: Real-world HbA1c study, PMC 2025